Health Care Sector Report : Video
Health, Video Friday, July 16th, 2010Health care issues are up before the bell, with GlaxoSmithKline (GSK) up over 2% pre-market on the NYSE as the FDA ruled that the British drug maker can keep its diabetes pill Avandia on the market even amid concerns about numerous side effects. GlaxoSmithKline also said that it will post about $2.4 billion in legal [...]